These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 19549739

  • 1. Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.
    Wimalawansa SJ, Grimes JP, Wilson AC, Hoover DR.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3356-64. PubMed ID: 19549739
    [Abstract] [Full Text] [Related]

  • 2. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial.
    Jamal SA, Hamilton CJ, Eastell R, Cummings SR.
    JAMA; 2011 Feb 23; 305(8):800-7. PubMed ID: 21343579
    [Abstract] [Full Text] [Related]

  • 3. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR, Wasnich RD, Recker R, Cauley JA, Chesnut CH, Ensrud KE, Burdeska A, Mills T, Oral Ibandronate Study Group.
    J Bone Miner Res; 2004 Jan 23; 19(1):11-8. PubMed ID: 14753731
    [Abstract] [Full Text] [Related]

  • 4. Osteoporosis prevention clinical study program.
    Delmas P, Gimona A.
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr 23; 64 Suppl():S39-45. PubMed ID: 8732473
    [Abstract] [Full Text] [Related]

  • 5. A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group.
    Delmas PD, Pornel B, Felsenberg D, Garnero P, Hardy P, Pilate C, Dain MP.
    Bone; 1999 May 23; 24(5):517-23. PubMed ID: 10321913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.
    Black DM, Bouxsein ML, Palermo L, McGowan JA, Newitt DC, Rosen E, Majumdar S, Rosen CJ, PTH Once-Weekly Research (POWR) Group.
    J Clin Endocrinol Metab; 2008 Jun 23; 93(6):2166-72. PubMed ID: 18349061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Bone HG, Bolognese MA, Yuen CK, Kendler DL, Wang H, Liu Y, San Martin J.
    J Clin Endocrinol Metab; 2008 Jun 23; 93(6):2149-57. PubMed ID: 18381571
    [Abstract] [Full Text] [Related]

  • 11. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S, Boermans AJ.
    Osteoporos Int; 2002 Jun 23; 13(2):176-83. PubMed ID: 11908492
    [Abstract] [Full Text] [Related]

  • 12. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis.
    Zhu HM, Qin L, Garnero P, Genant HK, Zhang G, Dai K, Yao X, Gu G, Hao Y, Li Z, Zhao Y, Li W, Yang J, Zhao X, Shi D, Fuerst T, Lu Y, Li H, Zhang X, Li C, Zhao J, Wu Q, Zhao SJ.
    Osteoporos Int; 2012 Apr 23; 23(4):1317-27. PubMed ID: 21505910
    [Abstract] [Full Text] [Related]

  • 13. Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.
    Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.
    Clin Ther; 2007 Sep 23; 29(9):1937-49. PubMed ID: 18035193
    [Abstract] [Full Text] [Related]

  • 14. The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
    Bhattoa HP, Bettembuk P, Balogh A, Szegedi G, Kiss E.
    Osteoporos Int; 2004 May 23; 15(5):396-404. PubMed ID: 14676992
    [Abstract] [Full Text] [Related]

  • 15. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
    Grimnes G, Joakimsen R, Figenschau Y, Torjesen PA, Almås B, Jorde R.
    Osteoporos Int; 2012 Jan 23; 23(1):201-11. PubMed ID: 21909730
    [Abstract] [Full Text] [Related]

  • 16. Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.
    Slatkovska L, Alibhai SM, Beyene J, Hu H, Demaras A, Cheung AM.
    Ann Intern Med; 2011 Nov 15; 155(10):668-79, W205. PubMed ID: 22084333
    [Abstract] [Full Text] [Related]

  • 17. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ, Laitinen K, Patronen A, Puolijoki H, Seppänen J, Pylkkänen L, Aranko SM, Sairanen S, Blåfield H, Rekiaro M, Väisänen K, Kormano M, Mäkinen L, Salmi J, Ala-Kaila K, Perttilä J, Vesterinen K, Koivunoro K, Probone Study Group.
    Osteoporos Int; 2002 Dec 15; 13(12):937-47. PubMed ID: 12459936
    [Abstract] [Full Text] [Related]

  • 18. Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women.
    Rubinacci A, Peruzzi E, Modena AB, Zanardi E, Andrei B, De Leo V, Pansini FS, Quebe-Fehling E, de Palacios PI.
    Menopause; 2003 Dec 15; 10(3):241-9. PubMed ID: 12792297
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss.
    McClung MR, Bolognese MA, Sedarati F, Recker RR, Miller PD.
    Bone; 2009 Mar 15; 44(3):418-22. PubMed ID: 18950736
    [Abstract] [Full Text] [Related]

  • 20. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
    Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.
    Osteoporos Int; 2006 Mar 15; 17(5):716-23. PubMed ID: 16463007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.